Aptamer selection and clinical application for C-reactive protein (CRP) based on magnetic-assisted rapid aptamer selection (MARAS)

Pao Yue-kong Library Electronic Theses Database

Aptamer selection and clinical application for C-reactive protein (CRP) based on magnetic-assisted rapid aptamer selection (MARAS)

 

Author: Li, Huanhao
Title: Aptamer selection and clinical application for C-reactive protein (CRP) based on magnetic-assisted rapid aptamer selection (MARAS)
Degree: M.Sc.
Year: 2016
Subject: C-reactive protein
Oligonucleotides.
Hong Kong Polytechnic University -- Dissertations
Department: Faculty of Engineering
Pages: vii, 68 pages : illustrations (some color)
Language: English
InnoPac Record: http://library.polyu.edu.hk/record=b2917030
URI: http://theses.lib.polyu.edu.hk/handle/200/8602
Abstract: Aptamer is one kind of single-strand nucleic acids specifically binding to target of interest and is generally screened by an in vitro method from a random oligonucleotide library using Systematic Evolution of Ligands by EXponential enrichment (SELEX). Utilizing the characteristic of magnetic nanoparticles, Magnetic-Assisted Rapid Aptamer Selection (MARAS) has recently been developed that greatly enhances the efficiency to select aptamers and provides a criteria for selecting aptamers with desired affinity. In this study, specific aptamers for C-reactive protein (CRP) are screened using this straightforward platform, MARAS, with a high affinity of Kd ~ 34 nM. The high specificity of aptamers in this study has been also achieved using multiple runs of negative selection, which is to eliminate the nonspecific binding of aptamers toward non-target biomolecules in serum samples. Selected aptamers are then used as capture ligands for detecting and quantifying the CRP content of forty blind serum samples. These results show a high correlation with those measured using Nephelometry method, one of golden standard to detect CRP using monoclonal anti-CRP antibody in clinical applications. Generally, antibody is necessary for protein detection, however, it is difficult and expensive for a common biological laboratory to produce as the inevitability for an in vivo process. Therefore, this excellent results of the blind test using aptamer-based detection are probably opening a great potential of aptamer to compete with antibody as targets of aptamers are not limited to proteins but antibody does.

Files in this item

Files Size Format
b29170308.pdf 3.688Mb PDF
Copyright Undertaking
As a bona fide Library user, I declare that:
  1. I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
  2. I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
  3. I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.

     

Quick Search

Browse

More Information